Holdings Channel
Size ($ in 1000's)
At 12/31/2023: $120,611
At 09/30/2023: $0

Combined Holding Report Includes:
Propel Bio Management LLC
Simplify Asset Management Inc.

Propel Bio Management LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Propel Bio Management LLC 13F filings. Link to 13F filings: SEC filings

Propel Bio Management LLC Top Holdings
As of  12/31/2023, below is a summary of the Propel Bio Management LLC top holdings by largest position size, as per the latest 13f filing made by Propel Bio Management LLC. In the Propel Bio Management LLC-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares held by Propel Bio Management LLC in that top holding, then the share count change between reporting periods, and finally the Propel Bio Management LLC top holding position size for that row.

   EntityAmountChange
 09/30/2023 to 12/31/2023
Position Size
($ in 1000's)
PLAINS GP HOLDINGS LP CL 1,372,360 +1,372,360 $21,889
     PAGP1,372,360+1,372,360$21,889
APPLIED THERAPEUTICS INC 5,374,982 +5,374,982 $18,006
     APLT5,374,982+5,374,982$18,006
TSCAN THERAPEUTICS INC 2,087,139 +2,087,139 $12,168
     TCRX2,087,139+2,087,139$12,168
MADRIGAL PHARMACEUTICALS INC 30,032 +30,032 $6,949
     MDGL30,032+30,032$6,949
CRINETICS PHARMACEUTICALS IN 165,000 +165,000 $5,871
     CRNX165,000+165,000$5,871
FULCRUM THERAPEUTICS INC 750,000 +750,000 $5,062
     FULC750,000+750,000$5,062
FIDELITY INV MMTRSY 1 680      $4,772
     COMM4,772,389+4,772,389$4,772
PHATHOM PHARMACEUTICALS INC 443,047 +443,047 $4,045
     PHAT443,047+443,047$4,045
DAY ONE BIOPHARMACEUTICALS I 270,664 +270,664 $3,952
     DAWN270,664+270,664$3,952
ARDELYX INC 594,174 +594,174 $3,684
     ARDX594,174+594,174$3,684
ATHIRA PHARMA INC 1,492,792 +1,492,792 $3,627
     ATHA1,492,792+1,492,792$3,627
TELESAT CORP 290,781 +290,781 $3,033
     TSAT290,781+290,781$3,033
SIMPLIFY ENHANCED INCOME 120,221 +120,221 $2,953
     HIGH120,221+120,221$2,953
AKERO THERAPEUTICS INC 100,052 +100,052 $2,336
     AKRO100,052+100,052$2,336
VANGUARD SHORT TERM BOND (BSV) 27,712 +27,712 $2,134
     BSV27,712+27,712$2,134
ISHARES IBONDS DEC 2024 T (IBDP) 85,442 +85,442 $2,128
     IBDP85,442+85,442$2,128
ISHARES MBS ETF (MBB) 22,400 +22,400 $2,107
     MBB22,400+22,400$2,107
MIRUM PHARMACEUTICALS INC 70,000 +70,000 $2,066
     MIRM70,000+70,000$2,066
MARINUS PHARMACEUTICALS INC 180,100 +180,100 $1,958
     MRNS180,100+180,100$1,958
KURA ONCOLOGY INC 130,000 +130,000 $1,869
     KURA130,000+130,000$1,869
AVIDITY BIOSCIENCES INC 178,500 +178,500 $1,615
     RNA178,500+178,500$1,615
KYMERA THERAPEUTICS INC 56,359 +56,359 $1,435
     KYMR56,359+56,359$1,435
SPDR PORT SHRT TRM CORP B (SPSB) 45,695 +45,695 $1,361
     SPSB45,695+45,695$1,361
KAYNE ANDERSON ENERGY INF 147,033 +147,033 $1,291
     KYN147,033+147,033$1,291
EIGER BIOPHARMACEUTICALS INC 4,391,432 +4,391,432 $986
     EIGR4,391,432+4,391,432$986
SUTRO BIOPHARMA INC 195,000 +195,000 $837
     STRO195,000+195,000$837
ISHARES 0 5 YR INV GRD CO (SLQD) 12,148 +12,148 $598
     SLQD12,148+12,148$598
ISHARES IBOXX INVESTMENT (LQD) 4,456 +4,456 $493
     LQD4,456+4,456$493
X4 PHARMACEUTICALS INC 535,000 +535,000 $449
     XFOR535,000+535,000$449
CYBIN INC 850,000 +850,000 $348
     CYBN850,000+850,000$348
SPDR BLOOMBERG INVESTMENT (FLRN) 9,267 +9,267 $283
     FLRN9,267+9,267$283
HERON THERAPEUTICS INC 104,195 +104,195 $177
     HRTX104,195+104,195$177
AGIOS PHARMACEUTICALS INC 5,792 +5,792 $129
     AGIO5,792+5,792$129

See Full List: All Stocks Held By Propel Bio Management LLC
— Including:
     • Biggest new positions
     • Biggest exits

See Details: Top 10 Stocks Held By Propel Bio Management LLC

Propel Bio Management LLC Top Holdings 13F Filings | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.